Galmed Pharma (GLMD) Updates on 'At-The-Market' Financing Program; Says ~$5M Raised

September 29, 2016 9:04 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) announced that, to date, it has raised approximately $5.0 million under the Company's At-The-Market financing executed by Cantor Fitzgerald (the "ATM"). In total, to date the Company has issued 933,160 ordinary shares under the ATM at an average sale price of $5.11 per share.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Equity Offerings

Related Entities

Cantor Fitzgerald

Add Your Comment